Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy B Moelans

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Breast Cancer Research and Treatment|November 16, 2011
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probesZsuzsanna Varga, Cathy B Moelans, Ursina Zuerrer-Hardi, et al.
Nature Reviews. Cancer|January 25, 2012
On the evidence for ESR1 amplification in breast cancerFrederik Holst, Cathy B Moelans, Martin Filipits, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenesCathy B Moelans, Roel A de Weger, Hanneke N Monsuur, et al.
Oncotarget|April 24, 2018
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancerCathy B Moelans, Caroline M G van Maldegem, Elsken van der Wall, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 12, 2011
Low frequency of HER2 amplification and overexpression in early onset gastric cancerCathy B Moelans, Anya N Milne, Folkert H Morsink, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 30, 2013
Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPACathy B Moelans, Jolien S de Groot, Xiaojuan Pan, et al.
BMC Cancer|November 24, 2014
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastasesLaura S Jiwa, Paul J van Diest, Laurien D Hoefnagel, et al.
American Journal of Clinical Pathology|September 16, 2011
Formaldehyde substitute fixatives. Analysis of macroscopy, morphologic analysis, and immunohistochemical analysisCathy B Moelans, Natalie ter Hoeve, Jan-Willem van Ginkel, et al.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Roel A de Weger, Hanneke N Monsuur, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 7, 2011
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Roel A de Wegers, Hanneke N Monsuurs, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Breast Cancer Research and Treatment|November 16, 2011
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probesZsuzsanna Varga, Cathy B Moelans, Ursina Zuerrer-Hardi, et al.
Nature Reviews. Cancer|January 25, 2012
On the evidence for ESR1 amplification in breast cancerFrederik Holst, Cathy B Moelans, Martin Filipits, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 18, 2010
Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenesCathy B Moelans, Roel A de Weger, Hanneke N Monsuur, et al.
Oncotarget|April 24, 2018
Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancerCathy B Moelans, Caroline M G van Maldegem, Elsken van der Wall, et al.
Cellular Oncology (Dordrecht, Netherlands)|March 12, 2011
Low frequency of HER2 amplification and overexpression in early onset gastric cancerCathy B Moelans, Anya N Milne, Folkert H Morsink, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 30, 2013
Clonal intratumor heterogeneity of promoter hypermethylation in breast cancer by MS-MLPACathy B Moelans, Jolien S de Groot, Xiaojuan Pan, et al.
BMC Cancer|November 24, 2014
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastasesLaura S Jiwa, Paul J van Diest, Laurien D Hoefnagel, et al.
American Journal of Clinical Pathology|September 16, 2011
Formaldehyde substitute fixatives. Analysis of macroscopy, morphologic analysis, and immunohistochemical analysisCathy B Moelans, Natalie ter Hoeve, Jan-Willem van Ginkel, et al.
Analytical Cellular Pathology (Amsterdam)|October 28, 2010
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Roel A de Weger, Hanneke N Monsuur, et al.
Cellular Oncology (Dordrecht, Netherlands)|May 7, 2011
Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification studyCathy B Moelans, Roel A de Wegers, Hanneke N Monsuurs, et al.
Pageof 8